Circulation Reports - Editor-in-Chief Message - Entering 8th Year With a Rising Impact Factor

Sep 30, 2026

Uploaded by Logic

Editorial message for Circulation Reports in its first 2026 issue, describing the journal’s launch in 2019 as an official Japanese Circulation Society sister journal and its indexing in PubMed Central in 2021. The editor highlights growth, achievement of the long-awaited impact factor for 2024, and expectations for 2025, then summarizes 2025 progress: submissions volume and composition, submission sources by country, manuscript categories, acceptance rate, and editorial processing timelines. Includes a Top 10 most frequently viewed papers list for Volume 7.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages3

Reading Time8 min

AccessFree to download

MESSAGE FROM THE EDITOR-IN-CHIEF

Circulation Reports entering 8th year with a rising impact factor

Submissions and manuscript types in 2025

Editorial process and timelines

Top 10 frequently viewed papers in Vol. 7

Circulation Reports Circ Rep 2026; 8: 1–3 doi:10.1253/circrep.CR-66-0022 MESSAGE FROM THE EDITOR-IN-CHIEF Circulation Reports Is Entering 8th Year With a Rising Impact Factor Masataka Sata, MD, PhD, FJCS Dear Colleagues, Welcome to the first issue of the Circulation Reports ( Circ Rep) in 2026. On January 10, 2019, Circ Rep, a sister journal of the Circulation Journal, was launched as an official Journal of the Japanese Circulation Society. During those 7 years, the journal has had great success in publishing many interesting papers, not only from Japan but also from all over the world. On March 12, 2021, all papers published in Circ Rep became searchable in PubMed Central® . Finally, Circ Rep has received its long-awaited impact factor!! The first impact factor for 2024 was as high as 1. 1, which is unusual for a newly launched journal. The official ranking places Circ Rep as 181th among the 230 journals in the Cardiac & Cardiovascular Systems category in 2024 JCR Science Citation Index Expanded Edition. Unofficial information suggests that the expected 2025 impact factor for Circ Rep will rise to around 2.0. I would like to ask readers to use Circ Rep papers as reference papers in your future submission of manuscripts to any journals. Here, I take an opportunity to summarize the progress of Circ Rep in 2025. Submissions Figure 1 shows the number of manuscripts submitted in 2025. We receive about 27 manuscripts each month. As of November 20, 2025, 279 manuscripts had been submitted: 69.5% de novo submissions and 30.5% transferred from Circulation Journal. Figure 2 shows the types of submitted manuscripts. Clinical Investigations and Images in Cardiovascular Medicine are the major categories, but we also received 9 Protocol Papers and 4 Statements/ Number of submissions in 2025 50 ~~ ~~ 40 30 20 10 ~~ ~~ 0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Figure 1. The number of manuscripts per month submitted in 2025. Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan Mailing address: Masataka Sata, MD, PhD, Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto-cho, Tokushima 770-8503, [Japan. email: masataka.sata@tokushima-u.ac.jp](Japan. email: masataka.sata@tokushima-u.ac.jp) All rights are reserved to the Japanese Circulation Society. For permissions, please email: [cr@j-circ.or.jp](cr@j-circ.or.jp) ISSN-2434-0790 Circulation Reports Vol.8, January 2026 | | Figure 2. Types of manuscripts submitted in 2025. | | --- | --- | | Figure 3. Countries from which submitted manuscripts in 2025.
| authors | | --- | --- | Opinion, which are unique categories of Circ Rep. Figure 3 shows from which countries the manuscripts were submitted. Submissions from Japan dominated, but we received manuscripts from Australia, China, France, Canada and India. Editorial Process The acceptance rate is 91.7% . Most of the manuscripts transferred from Circulation Journal have been accepted without delay after the editor-in-chief carefully checked the revised manuscripts and the authors’ replies to the original reviewers. In 2025, the average time from submission to acceptance was 29.4 days, and the average time from acceptance to advance online publication was 58.3 days. The editorial team continues efforts to minimize the time from submission to publication. Circulation Reports Vol.8, January 2026 Table. Top 10 Frequently Viewed Papers in Circulation Reports Vol. 7 Rank Access* Paper authors and title 1 2,803 Saito Y, Tateishi K, Kobayashi Y. Clinical review of cardiogenic shock after acute myocardial infarction: Revascularization, mechanical circulatory support, and beyond. Circ Rep 2024; 7: 6–14, doi:10.1253/circrep.CR-24- 0141. 2 2,797 Yoshida Y, Okayama S, Fujihara D, Taniyama M, Yamada A, Fukui M, et al. Effects of transcutaneous auricularvagus nerve stimula

FAQs

When was Circulation Reports launched and what key indexing milestone was achieved?

Circulation Reports was launched on January 10, 2019. Papers became searchable in PubMed Central on March 12, 2021.

What was the acceptance rate and the typical timeline in 2025?

The acceptance rate was 91.7%. The average time from submission to acceptance was 29.4 days, and from acceptance to advance online publication was 58.3 days.

How many manuscripts were submitted in 2025 and what were the major submission sources?

As of November 20, 2025, 279 manuscripts were submitted, with 69.5% de novo submissions and 30.5% transferred from Circulation Journal. Submissions were dominated by Japan, with additional manuscripts from Australia, China, France, Canada, and India.

Sep 30, 2026

Uploaded by Logic